Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov 6:12:945-949.
doi: 10.2147/JBM.S334689. eCollection 2021.

A Rare Association of Thrombotic Thrombocytopenic Purpura with Systemic Lupus Erythematosus in a Sudanese Woman: Case Report

Affiliations
Case Reports

A Rare Association of Thrombotic Thrombocytopenic Purpura with Systemic Lupus Erythematosus in a Sudanese Woman: Case Report

Amel Awad Ibn Idris Rodwan et al. J Blood Med. .

Abstract

Thrombotic thrombocytopenic purpura (TTP) is an uncommon life-threatening condition characterized by hemolytic disorders. The coexistence of systemic lupus erythematosus (SLE) with TTP is extremely rare, although Africans are at increased risk due to inherited risk factors. This report describes a rare clinical manifestation of TTP associated with SLE in a Sudanese patient. A 41-year-old Sudanese woman presented to the emergency department with symptoms and features that were suggestive of malaria, for which she had been treated accordingly. However, a few days later she complained of fever, and was found to have a body temperature of 39.5°C, jaundice, anemia, and thrombocytopenia. Soon after admission, she developed confusion and unrecordable blood pressure. After the patient had stabilized, clinical assessment, immune-system investigation (antinuclear antibody profile, complements, blood panel), and imaging revealed a diagnosis of TTP associated with SLE. The patient received imipenem 500 mg, five sessions of plasmapheresis (60 mL/kg), methylprednisolone 1 g pulse for 3 days, and rituximab 375 mg/week. Three weeks later, the patient was discharged after her condition had improved, and she is now on regular follow-up.

Keywords: African female; SLE; TTP; rituximab and plasmapheresis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Similar articles

Cited by

References

    1. Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006;1:6. PubMed PMID: 16722594. Pubmed Central PMCID: PMC1459118. doi:10.1186/1750-1172-1-6 - DOI - PMC - PubMed
    1. Adelowo OO, Oguntona SA. Pattern of systemic lupus erythematosus among Nigerians. Clin Rheumatol. 2009;28(6):699–703. PubMed PMID: 19242770. doi:10.1007/s10067-009-1139-6 - DOI - PubMed
    1. Fujimura Y, Isonishi A. [Pathophysiology of thrombotic thrombocytopenic purpura]. Nihon Jinzo Gakkai Shi. 2014;56(7):1043–1051. Japanese. PubMed PMID: 25420404. - PubMed
    1. Kremer Hovinga JA, Lammle B. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2012;2012:610–616. PubMed PMID: 23233642. doi:10.1182/asheducation.V2012.1.610.3798654 - DOI - PubMed
    1. Ali Z, Zafar MU, Wolfe Z, Akbar F, Lash B. Thrombotic thrombocytopenic purpura induced by immune checkpoint inhibitiors: a case report and review of the literature. Cureus. 2020;12(10):e11246. PubMed PMID: 33274128. Pubmed Central PMCID: PMC7707147. - PMC - PubMed

Publication types

LinkOut - more resources